Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia, Myeloid, Acute 13Myelodysplastic Syndromes 5Advanced Solid Tumors 5Advanced Solid Tumour 4Myeloproliferative Disorders 3Leukemia, Myelomonocytic, Chronic 3Small Cell Lung Carcinoma 2Recurrence 2Multiple Myeloma 2Carcinoma, Non-Small-Cell Lung 2Advanced Solid Tumor 2Advanced Lung Cancer 2Unresectable Locally Recurrent Breast Cancer 1Squamous Cell Carcinoma of Head and Neck 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Non-small Lung Cancer 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Multiple Sclerosis 1Metastatic Solid Tumors 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Monocytic, Acute 1Leukemia, Biphenotypic, Acute 1Idiopathic Pulmonary Fibrosis 1Digestive System Neoplasms 1Diffuse Intrinsic Pontine Glioma 1Depression 1

Interventions

Letrozole 4Fulvestrant 2Anastrozole 2toripalimab 1ribociclib 1palbociclib 1exemestane 1elacestrant 1disitamab vedotin 1abemaciclib 1Paclitaxel 1Lead 1Injections 1Goserelin 1AZD9833 1AZD5305 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Breast Cancer × Injections × 30 days × Clear all
NCT07591090 2026-05-15

A Phase II Study of AK146D1 Combined With AK112 in Advanced Breast Cancer

Akeso

Phase 2 Not yet recruiting
200 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡